Insulin costs need 'more work', even After Inflation bill.

By The Exchange Team

President Joe Biden signed a new legislative package Tuesday that helps Medicare beneficiaries pay for insulin to treat diabetes.

The Inflation Reduction Act doesn't extend cost limitations to all insulin-dependent patients.

Starting in 2023, Medicare Part D insulin copays will be $35. Medicare-covered seniors will have a $2,000 out-of-pocket cap on Part D prescription meds in 2025.

Dr. Robert Gabbay, chief scientific and medical officer at the American Diabetes Association, is excited about the financial reductions for seniors.

The Inflation Reduction Act was pushed by the Democrats through a process called "budget reconciliation" or "party majority."

In that procedure, the Senate Parliamentarian concluded non-Medicare insulin reform could not be included in the bill.

Senate senators needed 60 votes to include it. Only 57 MPs supported it, while 43 opposed it.